Kizilay F.Sahin M.Turna B.Altay B.Nazli O.Semerci B.2023-01-122023-01-122020002357760023-5776https://hdl.handle.net/11454/80115Objective: The aim of this study is to compare the outcomes of patients who underwent simultaneous transurethral resection of the prostate (TURP) and transurethral resection of bladder tumor (TURBT) with those who underwent only TURBT. Design: Historical-cohort Setting: Department of Urology, Ege University School of Medicine, Turkey Subjects: One hundred and eighty-six patients who underwent TUR were included in the study. Intervention: Tumor characteristics, complication, recurrence and progression rates, recurrence localizations, and elapsed time to recurrence were compared between the groups. Main outcome measures: Outcomes of simultaneous resection Results: The bladder tumor recurrence rate was 36.6% for group A and 29.8% for group B (P=.068), and the progression rates were 8.2% and 6.4%, respectively (P=.084). There was no significant difference between the elapsed time to recurrence (8.28±1.17 vs. 6.54±1.28 months) and the rate of prostatic urethral recurrence (1.8% vs. 1.7%, P=.712 and P=.395, respectively). Complication rates and progression distribution of tumors were also similar in both groups. Conclusion: It is safe to resect an incidentally detected bladder tumor along with prostate resection, with similar rates of progression, recurrence, and complications. © 2020, Kuwait Medical Association. All rights reserved.eninfo:eu-repo/semantics/closedAccessBenign prostatic hyperplasiaBladder tumorProgressionRecurrenceTransurethral resectioncefazolinfurosemideadultArticlebladder cancerbladder tumorblood transfusioncancer growthcancer localizationcancer recurrencecancer stagingcohort analysiscystectomycystoscopyendoscopyfemalefeverfollow uphematuriahumanhypertensionInternational Prostate Symptom Scoremajor clinical studymalemiddle agednuclear magnetic resonance imagingoutcome assessmentpostoperative complicationpostvoid residual urine volumeprostate hypertrophyprostate tumorprostate urethraprostatectomyspinal anesthesiatransitional cell carcinomatransurethral resectiontumor recurrenceurinary tract infectionurine cultureurine retentionuroflowmetryArticle5232682732-s2.0-85090594672N/A